People Background Check
Find People:

William Stephen Mow, Age 55Irvine, CA

Get Report
Known as:
William S Mow William Santos Mow William Santos Tr Mow William Stephen

William Mow Phones & Addresses

Irvine, CA

Tustin, CA

4317 Lilac Ridge Rd, San Ramon, CA 94582 (925) 968-9455

4936 Beloit Ave, Culver City, CA 90230

Los Angeles, CA

Chico, CA

Chicago, IL

Harbor City, CA

Show more

Social networks

William Stephen Mow

Linkedin

Work

Company: Kaiser Permanente Hayward Medical Center Address: 27400 Hesperian Boulevard, Hayward, CA 94545

Education

School / High School: University Of Chicago/The Pritzker School Of Medicine 1997

Languages

English • Chinese • Spanish • Vietnamese

Awards

Healthgrades Honor Roll

Ranks

Certificate: Pediatric Gastroenterology, 2011

Mentions for William Stephen Mow

Career records & work history

Medicine Doctors

William Mow Photo 1

Dr. William S Mow, Hayward CA - MD (Doctor of Medicine)

Specialties:
Pediatric Gastroenterology
Address:
27400 Hesperian Blvd, Hayward, CA 94545
(510) 784-4000 (Phone) (800) 464-4000 (Fax)
411 N Lakeview Ave, Anaheim, CA 92807
(866) 984-7483 (Phone) (909) 609-2974 (Fax)
Certifications:
Pediatric Gastroenterology, 2011
Pediatrics, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Chinese
Spanish
Vietnamese
Hospitals:
27400 Hesperian Blvd, Hayward, CA 94545
411 N Lakeview Ave, Anaheim, CA 92807
Kaiser Permanente Hayward Medical Center
27400 Hesperian Boulevard, Hayward, CA 94545
Education:
Medical School
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1997
Medical School
La Co Harbor UCLA Med Center
Graduated: 1997
Medical School
UCLA Med Ctr/UCLA D Geffen School
Graduated: 1997
William Mow Photo 2

William Stephen Mow, Anaheim CA

Specialties:
Pediatrics
Pediatric Gastroenterology
Gastroenterology
Work:
Lakeview Medical Offices
411 N Lakeview Ave, Anaheim, CA 92807Kaiser Foundation Hospital - Hayward
27400 Hesperian Blvd, Hayward, CA 94545
Education:
University of Chicago (1997)
William Mow Photo 3

William Stephen Mow, Hayward CA

Specialties:
Pediatrician
Address:
27400 Hesperian Blvd, Hayward, CA 94545
411 N Lakeview Ave, Anaheim, CA 92807
Education:
University of Chicago, Pritzker School of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics
American Board of Pediatrics Sub-certificate in Pediatric Gastroenterology (Pediatrics)

William Mow resumes & CV records

Resumes

William Mow Photo 18

William Mow

Publications & IP owners

Wikipedia

William Mow Photo 19

Bugle Boy

William Mow (Traditional Chinese: ) was born in Hang-Chow, China, and later moved with his family to the United States. He graduated from Rensselaer ...

Us Patents

Methods Of Assessing Crohn's Disease Patient Phenotype By I2 Serologic Response

US Patent:
8163501, Apr 24, 2012
Filed:
Dec 22, 2009
Appl. No.:
12/645394
Inventors:
Stephen R. Targan - Santa Monica CA, US
Eric A. Vasiliauskas - Manhattan Beach CA, US
William S. Mow - Culver City CA, US
Huiying Yang - Cerritos CA, US
Phillip R. Fleshner - Beverly Hills CA, US
Jerome I. Rotter - Los Angeles CA, US
Assignee:
Cedars-Sinai Medical - Los Angeles CA
International Classification:
G01N 33/53
G01N 33/542
G01N 33/00
US Classification:
435 71, 435 79, 435 792
Abstract:
The invention provides a method of diagnosing or predicting susceptibility to a clinical subtype of Crohn's disease in a subject having Crohn's disease by determining the presence or absence of IgA anti-I2 antibodies in the subject, where the presence of the IgA anti-I2 antibodies indicates that the subject has a clinical subtype of Crohn's disease. In one embodiment, a method of the invention is practiced by further determining the presence or absence in the subject of a NOD2 variant, anti-antibodies (ASCA), IgA anti-OmpC antibodies, or perinuclear anti-neutrophil cytoplasmic antibodies (pANCA). The methods of the invention can be used to diagnose or predict susceptibility to a clinical subtype of Crohn's disease, for example, a fibrostenotic subtype, a subtype characterized by the need for small bowel surgery, or a subtype characterized by the absence of features of ulcerative colitis.

Methods Of Assessing Crohn's Disease Patient Phenotype By L2 Serologic Response

US Patent:
2004020, Oct 14, 2004
Filed:
Apr 11, 2003
Appl. No.:
10/413501
Inventors:
Stephan Targan - Santa Monica CA, US
Eric Vasiliauskas - Manhattan Beach CA, US
William Mow - Culver City CA, US
Huiying Yang - Cerritos CA, US
Phillip Fleshner - Beverly Hills CA, US
Jerome Rotter - Los Angeles CA, US
International Classification:
G01N033/53
G01N033/567
G01N033/543
C12Q001/68
US Classification:
435/007200, 436/518000
Abstract:
The invention provides a method of diagnosing or predicting susceptibility to a clinical subtype of Crohn's disease in a subject having Crohn's disease by determining the presence or absence of IgA anti-I2 antibodies in the subject, where the presence of the IgA anti-I2 antibodies indicates that the subject has a clinical subtype of Crohn's disease. In one embodiment, a method of the invention is practiced by further determining the presence or absence in the subject of a NOD2 variant, anti-antibodies (ASCA), IgA anti-OmpC antibodies, or perinuclear anti-neutrophil cytoplasmic antibodies (pANCA). The methods of the invention can be used to diagnose or predict susceptibility to a clinical subtype of Crohn's disease, for example, a fibrostenotic subtype, a subtype characterized by the need for small bowel surgery, or a subtype characterized by the absence of features of ulcerative colitis.

Methods Of Assessing Crohn's Disease Patient Phenotype By I2, Ompc And Asca Serologic Response

US Patent:
2005005, Mar 10, 2005
Filed:
Nov 26, 2003
Appl. No.:
10/723164
Inventors:
Stephan Targan - Santa Monica CA, US
Eric Vasiliauskas - Manhattan Beach CA, US
William Mow - San Ramon CA, US
Huiying Yang - Cerritos CA, US
Phillip Fleshner - Beverly Hills CA, US
Jerome Rotter - Los Angeles CA, US
International Classification:
G01N033/53
G01N033/537
G01N033/543
US Classification:
435007920
Abstract:
The invention provides a method of diagnosing or predicting susceptibility to a clinical subtype of Crohn's disease in a subject having Crohn's disease by determining the presence or absence of IgA anti-I2 antibodies in the subject, where the presence of the IgA anti-I2 antibodies indicates that the subject has a clinical subtype of Crohn's disease. In one embodiment, a method of the invention is practiced by further determining the presence or absence in the subject of a NOD2 variant, anti-Saccharomyces cerevisiae antibodies (ASCA), IgA anti-OmpC antibodies, or perinuclear anti-neutrophil cytoplasmic antibodies (pANCA). The methods of the invention can be used to diagnose or predict susceptibility to a clinical subtype of Crohn's disease, for example, a fibrostenotic subtype, a subtype characterized by the need for small bowel surgery, or a subtype characterized by the absence of features of ulcerative colitis.

Methods Of Assessing Crohn's Disease Patient Phenotype By I2, Ompc And Asca Serologic Response

US Patent:
2012020, Aug 16, 2012
Filed:
Dec 6, 2011
Appl. No.:
13/312960
Inventors:
Stephan R. Targan - Santa Monica CA, US
Eric A. Vasiliauskas - Manhattan Beach CA, US
William S. Mow - San Ramon CA, US
Huiying Yang - Cerritos CA, US
Phillip R. Fleshner - Beverly Hills CA, US
Jerome I. Rotter - Los Angeles CA, US
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
G01N 33/566
US Classification:
435 792, 436501
Abstract:
The invention provides a method of diagnosing or predicting susceptibility to a clinical subtype of Crohn's disease in a subject having Crohn's disease by determining the presence or absence of IgA anti-I2 antibodies in the subject, where the presence of the IgA anti-I2 antibodies indicates that the subject has a clinical subtype of Crohn's disease. In one embodiment, a method of the invention is practiced by further determining the presence or absence in the subject of a NOD2 variant, anti-antibodies (ASCA), IgA anti-OmpC antibodies, or perinuclear anti-neutrophil cytoplasmic antibodies (pANCA). The methods of the invention can be used to diagnose or predict susceptibility to a clinical subtype of Crohn's disease, for example, a fibrostenotic subtype, a subtype characterized by the need for small bowel surgery, or a subtype characterized by the absence of features of ulcerative colitis.

Possible Relatives

Michael A Mow  Milton V Mow  William R Stamps  William J Stanaland  William J Stancil  William R Standifer  William W Standiford  William J Standish  William R White  William L Jolly 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.